These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6369734)

  • 81. Is Pump Therapy for All with Type 1 Diabetes?
    Wilson DM
    Diabetes Technol Ther; 2016 May; 18(5):280-1. PubMed ID: 27159783
    [No Abstract]   [Full Text] [Related]  

  • 82. [An overview of so far published analyses comparating the effectiveness of the treatment with insulin pump and multiple daily injections in type 1 diabetes mellitus].
    Hendrychová T; Matoulková P; Vlček J; Smahelová A
    Vnitr Lek; 2012 Feb; 58(2):89-93. PubMed ID: 22463086
    [TBL] [Abstract][Full Text] [Related]  

  • 83. 'Do-it-yourself' insulin pump. Case report.
    Bruttomesso D; Lisato G; Del Prato S; Tiengo A
    Acta Diabetol Lat; 1989; 26(1):75-8. PubMed ID: 2750447
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Comparison of metabolic and psychological parameters during continuous subcutaneous insulin infusion and intensified conventional insulin treatment in type I diabetic patients.
    Schottenfeld-Naor Y; Galatzer A; Karp M; Josefsberg Z; Laron Z
    Isr J Med Sci; 1985 Oct; 21(10):822-8. PubMed ID: 3908396
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Continuous subcutaneous insulin infusion pump treatment in children with type 1 diabetes mellitus.
    Liberatore R; Perlman K; Buccino J; Artiles-Sisk A; Daneman D
    J Pediatr Endocrinol Metab; 2004 Feb; 17(2):223-6. PubMed ID: 15055358
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Efficacy and Safety of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Injections on Type 1 Diabetes Children: A Meta-Analysis of Randomized Control Trials.
    Qin Y; Yang LH; Huang XL; Chen XH; Yao H
    J Clin Res Pediatr Endocrinol; 2018 Nov; 10(4):316-323. PubMed ID: 30015622
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial.
    Feig DS; Corcoy R; Donovan LE; Murphy KE; Barrett JFR; Sanchez JJ; Wysocki T; Ruedy K; Kollman C; Tomlinson G; Murphy HR;
    Diabetes Care; 2018 Dec; 41(12):2471-2479. PubMed ID: 30327362
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.
    Gin H; Renard E; Melki V; Boivin S; Schaepelynck-Bélicar P; Guerci B; Selam JL; Brun JM; Riveline JP; Estour B; Catargi B;
    Diabetes Metab; 2003 Dec; 29(6):602-7. PubMed ID: 14707889
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Cost benefits of intensive insulin therapy using injections, external pumps and implantable pumps].
    Selam JL; Haardt MJ; Berne C; Dorange C; Lanoe JL; Bethoux JP; Slama G
    Diabete Metab; 1993 Dec; 19(5 Suppl):506-9. PubMed ID: 8206188
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Continuous subcutaneous insulin infusion treatment in insulin-dependent diabetic patients: a comparison with conventional optimized treatment in a long-term study.
    Calabrese G; Bueti A; Santeusanio F; Giombolini A; Zega G; Angeletti G; Cartechini MG; Brunetti P
    Diabetes Care; 1982; 5(5):457-65. PubMed ID: 7188333
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Percentage of Continuous Subcutaneous Insulin Infusion Usage Among Adult Type 1 Diabetes Mellitus Patients in Japan: A Cross-Sectional Study at National Hospital Organization Hospitals.
    Murata T; Aoki Y; Kato Y; Tanaka T; Araki R; Kato K; Hida K; Kawamura T; Yoshida K; Imamura Y; Toyonaga T; Yamada K; Sakane N;
    J Diabetes Sci Technol; 2017 Sep; 11(5):1055-1056. PubMed ID: 28859515
    [No Abstract]   [Full Text] [Related]  

  • 93. Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes.
    De Valk HW; Lablanche S; Bosi E; Choudhary P; Silva JD; Castaneda J; Vorrink L; De Portu S; Cohen O
    Diabetes Technol Ther; 2018 Nov; 20(11):758-766. PubMed ID: 30325656
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up.
    van Dijk PR; Logtenberg SJ; Groenier KH; Gans RO; Kleefstra N; Bilo HJ
    BMC Endocr Disord; 2014 Apr; 14():30. PubMed ID: 24708696
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Moreno-Fernandez J; Pazos-Couselo M; González-Rodriguez M; Rozas P; Delgado M; Aguirre M; Garcia-Lopez JM
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):556-563. PubMed ID: 29907546
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Impact of sensor-augmented pump therapy with predictive low-glucose management on hypoglycemia and glycemic control in patients with type 1 diabetes mellitus: 1-year follow-up.
    Gómez AM; Henao DC; Taboada LB; Leguizamón G; Rondón MA; Muñoz OM; García-Jaramillo MA; León Vargas FM
    Diabetes Metab Syndr; 2019; 13(4):2625-2631. PubMed ID: 31405686
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Intensive conventional and insulin pump therapies in adult type I diabetes. A crossover study.
    Nathan DM; Lou P; Avruch J
    Ann Intern Med; 1982 Jul; 97(1):31-6. PubMed ID: 7046554
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Intensive management of type 1 diabetes in young children.
    Kaufman FR
    Lancet; 2005 Feb 26-Mar 4; 365(9461):737-8. PubMed ID: 15733703
    [No Abstract]   [Full Text] [Related]  

  • 100. A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump.
    Raskin P; Holcombe JH; Tamborlane WV; Malone JI; Strowig S; Ahern JA; Lavent F
    J Diabetes Complications; 2001; 15(6):295-300. PubMed ID: 11711322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.